No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma

被引：0
作者：
Melody, Megan [1 ,2 ]
Franco, Stephanie [3 ]
Odetola, Oluwatobi [1 ,2 ]
Lin, Adam [1 ,2 ]
Moreira, Jonathan [1 ,2 ]
Carson, Kenneth [1 ,2 ]
Ma, Shuo [1 ,2 ]
Winter, Jane N. [1 ,2 ]
Gordon, Leo [1 ,2 ]
Karmali, Reem [1 ,2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
CT; LBCL; CAR T-cell therapy; CRS; ICANS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-630
引用
收藏
页码：S611 / S612
页数：2
相关论文
共 50 条
  • [21] Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Prieto, Marcela Martinez
    Bollu, Vamsi
    Kuzan, David
    Maziarz, Richard
    Kersten, Marie Jose
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S380 - S381
  • [22] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Hideki Goto
    Shinichi Makita
    Koji Kato
    Kota Tokushige
    Taizo Fujita
    Koichi Akashi
    Koji Izutsu
    Takanori Teshima
    [J]. International Journal of Clinical Oncology, 2020, 25 : 1736 - 1743
  • [23] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Goto, Hideki
    Makita, Shinichi
    Kato, Koji
    Tokushige, Kota
    Fujita, Taizo
    Akashi, Koichi
    Izutsu, Koji
    Teshima, Takanori
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1736 - 1743
  • [24] Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma
    Lim, Chae Hong
    Yoon, Sang Eun
    Kim, Won Seog
    Lee, Kyung-Han
    Kim, Seok Jin
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7289 - 7297
  • [25] Matching-Adjusted Indirect Comparison of Axicabtagene Ciloleucel vs Odronextamab for the Treatment of Relapsed/Refractory (R/R) Large B- Cell Lymphoma (LBCL) After 2 Prior Lines of Systemic Treatment
    Locke, Frederick L.
    Popoff, Evan
    Wade, Sally W.
    Limbrick-Oldfield, Eve
    Kanters, Steve
    Palivela, Madhu
    Best, Timothy
    Ray, Markqayne
    Oluwole, Olalekan O.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S478 - S478
  • [26] Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
    Modi, Dipenkumar
    Potugari, Bindu
    Uberti, Joseph
    [J]. CANCERS, 2021, 13 (22)
  • [27] Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma
    Adams, Hugo J. A.
    de Klerk, John M. H.
    Fijnheer, Rob
    Dubois, Stefan V.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (03) : 372 - 377
  • [28] Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies
    Hersby, Ditte Stampe
    Schejbel, Lone
    Breinholt, Marie Fredslund
    Hogdall, Estrid
    Norgaard, Peter
    Nielsen, Torsten Holm
    Pedersen, Lars Moller
    Gang, Anne Ortved
    [J]. ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5835 - 5848
  • [29] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [30] FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma
    Jo, Joon-Hyung
    Chung, Hyun Woo
    Kim, Sung-Yong
    Lee, Mark Hong
    So, Young
    [J]. NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 57 (01) : 26 - 33
12345